17 February 2023: Clinical Research
EXOC3L1: A Novel Prognostic Biomarker Correlated with Immune Infiltration in Esophageal Squamous Cell Carcinoma
Zhan-Fei Zhang 12ABCDEFG*DOI: 10.12659/MSM.938512
Med Sci Monit 2023; 29:e938512
Figure 2 High expression of EXOC3L1 was associated with worse prognosis in patients with ESCC(A) Among the ESCC patients from TCGA, the expression of EXOC3L1 was significantly correlated with N stage. (B) High expression of EXOC3L1 was associated with higher pathological stage. (C) The ESCC patients with high EXOC3L1 expression had a shorter OS, DSS, and PFI.